Поиск
Sign in
PROIPO.PRO
Menu
IPO review
Inozyme Pharma
NASDAQ INZY
Industry Health Care
IPO Date 23.07.2020
Trade Date 24.07.2020

More
PROIPO SMART RATING Доступно
по тарифу IPO
Institutional Investor Demand Платный блок
Analysts' expectations Платный блок
IPO Market Sentiment Positive
IPO Price
$16
IPO parameters
  • IPO Price $16
  • Price Range $14 - $16
  • Offer Shares 7 млн.
    5 млн.
  • Deal Size $112 млн.
    80 млн.
  • Total Shares 24.12 млн.
  • Capitalization $386 млн.
  • Enterprise Value $210 млн.
  • Underwriter BofA
Notes

No notes

Company Information
  • Headquarter Boston, MA
  • Year of foundation 2015
  • Website Inozyme Pharma
  • Employees 24
Lockup
  • Lock-Up (3M) 26.10.2020
  • Lock-Up (6M) 20.01.2021
  • Окночание техого периода 18.08.2020
  • Отчетный день 05.11.2024
  • Profitability
  • Growth
  • Debt 0x Low
  • 24.07.2020 GAP (1D)
    $20.8 +30%
  • 24.07.2020 Profitability (1D)
    $17.54 +9.6%
  • 26.10.2020 Profitability (3M)
    $23.61 +47.6%
  • 20.01.2021 Profitability (6M)
    $27.17 +69.8%
Financial Data
Sales (LTM) $ 0 M
Growth (YoY)
-
Gross Margin -
EBITDA -
Net Income $ -22 M
Ratios
Market Cap. $ 386 M
Enterprise Value $ 210 M
EV/Sales -
EV/EBITDA -
P/E -

Отчет о прибылях и убытках

Продажи
N/A N/A
Валовая прибыль
N/A N/A
EBITDA
2018 $-11 M
2019 $-20 M
EBIT
2018 $-12 M
2019 $-21 M

Баланс

124%
Денежные средства
До IPO $75 M
После IPO $168 M
122%
Активы
До IPO $76 M
После IPO $169 M
Долги
N/A N/A
131%
Капитал
До IPO $71 M
После IPO $164 M
Latest 10 IPOs in the Health Care sector
Компания
Тикер
Рейтинг
Дата
Цена
Изменение
BSC
Basic
17.03.2021
$21
+100%
`
BSC
Basic
17.03.2021
$21
+100%
`
BSC
Basic
17.03.2021
$21
+100%
`
BSC
Basic
17.03.2021
$21
+100%
`
BSC
Basic
17.03.2021
$21
+100%
`
BSC
Basic
17.03.2021
$21
+100%
`
BSC
Basic
17.03.2021
$21
+100%
`
BSC
Basic
17.03.2021
$21
+100%
`
BSC
Basic
17.03.2021
$21
+100%
`
BSC
Basic
17.03.2021
$21
+100%
`